PH News

I wrote No Cure for Me as a long-time survivor of pulmonary hypertension. Knowing that I may be one of Canada’s longest survivors, it sparked a thought—what if one day I became the world’s longest survivor? I’ve set my sights on living to 103, and along the way, I couldn’t help but imagine how remarkable it would be to earn a place in the Guinness World Records. That idea—part hope, part determination—became the seed for this thriller. Writing it was my way of blending realit

Pulmonary arterial hypertension (PAH) patient Nicole Dempsey was involved in developing a new online Continuing Medical Education course, PAH in Practice: A Case-based Online Learning Program for Better Patient Care, alongside pulmonary hypertension experts Dr. Steeve Provencher, Dr. Kristina Kemp, and Dr. Rhea Varughese. This type of training is an important step forward in improving awareness and understanding of this rare condition: because PAH symptoms can be nonspecific

This week is Heart Failure Awareness Week. As this year's awareness campaign says, it's not normal to be breathless! Heart failure is, unfortunately, one of the consequences of pulmonary hypertension. The right side of the heart can adapt for a while by getting thicker and stronger, but it's hard to tell why it eventually starts to fail, and this happens at different times for different patients. Raising awareness about this serious condition is important: early detection hel

May 4-10 is Mental Health Week in Canada, and the theme is “Come Together, Canada.” PHA Canada Knowledge Philanthropist Lisa Harder talks about the meaning of connection. This year’s theme for Mental Health Week is all about the importance of connectedness in our overall well-being. Both social connections and connection with ourselves helps to foster resilience and to reduce the sense of isolation we may feel (Canadian Mental Health Association, 2026). While we can recogn

Two companies have announced good results from clinical trials in the past few weeks. Merck’s Phase 2 proof-of-concept CADENCE trial of two different doses of sotatercept for some Group 2 pulmonary hypertension patients succeeded. Trial participants had combined post- and precapillary pulmonary hypertension and heart failure with preserved ejection fraction (CpcPH-HFpEF). Participants who received sotatercept showed significant improvements in their pulmonary vascular resista

April 7 is National Caregiver Day Many pulmonary hypertension patients have caregivers, whether they’re the partners, parents, or children of patients. Caregivers make a major difference in patients’ lives, helping them manage their pulmonary hypertension and daily routines. Nearly half of patients with pulmonary arterial hypertension rely on the help of a caregiver, underscoring just how essential this support truly is. Caregivers often take on a wide range of responsibiliti